Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome
Journal of Allergy and Clinical Immunology · 2023-04 · 151 (4) · 1081-1095
DOI: 10.1016/j.jaci.2022.09.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023-04. Verfasst von Jennifer W Leiding und 59 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore; Johns Hopkins All Children's In…. Hauptthemen laut MEDLINE: Immune System Diseases, Immunologic Deficiency Syndromes. Die Arbeit wurde bisher 130-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NIAID NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
BACKGROUND: In 2014, germline signal transducer and activator of transcription (STAT) 3 gain-of-function (GOF) mutations were first described to cause a novel multisystem disease of early-onset lymphoproliferation and autoimmunity. OBJECTIVE: This pivotal cohort study defines the scope, natural history, treatment, and overall survival of a large global cohort of patients with pathogenic STAT3 GOF variants. METHODS: We identified 191 patients from 33 countries with 72 unique mutations. Inclusion criteria included symptoms of immune dysregulation and a biochemically confirmed germline heterozygous GOF variant in STAT3. RESULTS: Overall survival was 88%, median age at onset of symptoms was 2.3 years, and median age at diagnosis was 12 years. Immune dysregulatory features were present in all patients: lymphoproliferation was the most common manifestation (73%); increased frequencies of double-negative (CD4-CD8-) T cells were found in 83% of patients tested. Autoimmune cytopenias were the second most common clinical manifestation (67%), followed by growth delay, enteropathy, skin disease, pulmonary disease, endocrinopathy, arthritis, autoimmune hepatitis, neurologic disease, vasculopathy, renal disease, and malignancy. Infections were reported in 72% of the cohort. A cellular and humoral immunodeficiency was observed in 37% and 51% of patients, respectively. Clinical symptoms dramatically improved in patients treated with JAK inhibitors, while a variety of other immunomodulatory treatment modalities were less efficacious. Thus far, 23 patients have undergone bone marrow transplantation, with a 62% survival rate. CONCLUSION: STAT3 GOF patients present with a wide array of immune-mediated disease including lymphoproliferation, autoimmune cytopenias, and multisystem autoimmunity. Patient care tends to be siloed, without a clear treatment strategy. Thus, early identification and prompt treatment implementation are lifesaving for STAT3 GOF syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore; Johns Hopkins All Children's Institute for Clinical and Translational Research, Johns Hopkins All Chi…
- Department of Pediatrics, Baylor College of Medicine and William T. Shearer Center for Human Immunobiology, Texas Children's Hospital, Houston.
- Lake Erie College of Osteopathic Medicine, Erie.
- Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa.
- Department of Cell and Molecular Biology, St Jude Children's Research Hospital, Memphis.
- Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston.
Förderung
- Wellcome Trust
- NIAID NIH HHS
- Intramural NIH HHS
- Baylor College of Medicine
- National Institutes of Health
- National Health and Medical Research Council
- National Institute of Allergy and Infectious Diseases
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Leiding, J. W., Vogel, T. P., Santarlas, V. G. J., Mhaskar, R., Smith, M. R., Carisey, A., Vargas-Hernández, A., Silva-Carmona, M., Heeg, M., Rensing-Ehl, A., Neven, B., Hadjadj, J., Hambleton, S., Ronan Leahy, T., Meesilpavikai, K., Cunningham-Rundles, C., Dutmer, C. M., Sharapova, S. O., Taskinen, M., …, & Cook, M. C. (2023). Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome. Journal of Allergy and Clinical Immunology, 151(4), 1081-1095. https://doi.org/10.1016/j.jaci.2022.09.002
Vancouver
Leiding JW, Vogel TP, Santarlas VGJ, Mhaskar R, Smith MR, Carisey A, et al. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome. Journal of Allergy and Clinical Immunology. 2023;151(4):1081-1095. doi:10.1016/j.jaci.2022.09.002
BibTeX
@article{Leiding2023,
author = {Leiding, Jennifer W and Vogel, Tiphanie P and Santarlas, Valentine G J and Mhaskar, Rahul and Smith, Madison R and Carisey, Alexandre and Vargas-Hernández, Alexander and Silva-Carmona, Manuel and Heeg, Maximilian and Rensing-Ehl, Anne and Neven, Bénédicte and Hadjadj, Jérôme and Hambleton, Sophie and Ronan Leahy, Timothy and Meesilpavikai, Kornvalee and Cunningham-Rundles, Charlotte and Dutmer, Cullen M and Sharapova, Svetlana O and Taskinen, Mervi and Chua, Ignatius and Hague, Rosie and Klemann, Christian and Kostyuchenko, Larysa and Morio, Tomohiro and Thatayatikom, Akaluck and Ozen, Ahmet and Scherbina, Anna and Bauer, Cindy S and Flanagan, Sarah E and Gambineri, Eleonora and Giovannini-Chami, Lisa and Heimall, Jennifer and Sullivan, Kathleen E and Allenspach, Eric and Romberg, Neil and Deane, Sean G and Prince, Benjamin T and Rose, Melissa J and Bohnsack, John and Mousallem, Talal and Jesudas, Rohith and Santos Vilela, Maria Marluce Dos and O'Sullivan, Michael and Pachlopnik Schmid, Jana and Průhová, Štěpánka and Klocperk, Adam and Rees, Matthew and Su, Helen and Bahna, Sami and Baris, Safa and Bartnikas, Lisa M and Chang Berger, Amy and Briggs, Tracy A and Brothers, Shannon and Bundy, Vanessa and Chan, Alice Y and Chandrakasan, Shanmuganathan and Christiansen, Mette and Cole, Theresa and Cook, Matthew C},
title = {Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome},
journal = {Journal of Allergy and Clinical Immunology},
year = {2023},
volume = {151},
number = {4},
pages = {1081--1095},
doi = {10.1016/j.jaci.2022.09.002}
}
EUVIMED